SENP2 and posterior cortical atrophy: In conclusion, the present study combined in vitro experiments and bioinformatics analyses to elucidate the antiproliferative and anti-clonogenic potential of the NSC632839 small molecule inhibitor and identified the expression profile of SENP2 as a relevant target in PCa disease progression.